LEADER 03966nam  22006975  450 
001 9910624392103321
005 20240916134952.0
010   $a9789811947117$b(electronic bk.)
010   $z9789811947100
024 7 $a10.1007/978-981-19-4711-7
035   $a(MiAaPQ)EBC7126514
035   $a(Au-PeEL)EBL7126514
035   $a(CKB)25208249000041
035   $a(DE-He213)978-981-19-4711-7
035   $a(PPN)265859492
035   $a(EXLCZ)9925208249000041
100   $a20221025d2022      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPersonalization in Gynecologic Oncology /$fedited by Masaki Mandai
205   $a1st ed. 2022.
210  1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2022.
215   $a1 online resource (149 pages)
225 1 $aComprehensive Gynecology and Obstetrics,$x2364-219X
311 08$aPrint version: Mandai, Masaki Personalization in Gynecologic Oncology Singapore : Springer,c2022 9789811947100 
320   $aIncludes bibliographical references.
327   $a1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit.
330   $aThis book thoroughly illustrates the designed and tailored medical approaches for tumors of the female reproductive organ. The chapters explore different cancer species such as ovarian cancer, endometrial cancer, cervical cancer, etc. Various treatment modalities such as immunotherapy and histotype-specific treatment are delivered, and it offers a chapter on how genome-wide analysis contributes to personalized treatment. It is essential to understand this concept because many molecular target drugs and the prevalence of genome-based analysis in clinical settings have enabled us to introduce valid precision medicine in the field of gynecologic oncology. Chapters explain the stream of transition from conventional standardized treatment to personalized treatment and address future perspectives. Personalization Gynecologic Oncology is a well-designed source for beginning to advanced oncologists, gynecologists, geneticists, genetic counselors, and nurses. Offering the latest treatment strategies, the Editor hopes the ideas presented here will be a foundation for further development in the field. .
410  0$aComprehensive Gynecology and Obstetrics,$x2364-219X
606   $aOncology
606   $aGynecology
606   $aCancer$xGenetic aspects
606   $aTumor markers
606   $aOncology
606   $aGynecology
606   $aCancer Genetics and Genomics
606   $aTumour Biomarkers
606   $aAparell genital femení$2thub
606   $aCàncer$2thub
608   $aLlibres electrònics$2thub
615  0$aOncology.
615  0$aGynecology.
615  0$aCancer$xGenetic aspects.
615  0$aTumor markers.
615 14$aOncology.
615 24$aGynecology.
615 24$aCancer Genetics and Genomics.
615 24$aTumour Biomarkers.
615  7$aAparell genital femení
615  7$aCàncer
676   $a616.99465
702   $aMandai$b Masaki
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
912   $a9910624392103321
996   $aPersonalization in Gynecologic Oncology$92963391
997   $aUNINA